Dolphin Intertrade Xiyouji Qingzhi Capsule Recall: FDA Class I

Why it was recalled

Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.

Product description

XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box

Lot numbers, UPCs & expiration codes

All Lots

Where it was sold

Nationwide

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-1250-2014
Classification: Class I
Status: Terminated
Recall initiated: May 20, 2013
FDA report date: Apr 30, 2014
Quantity: 8 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Dolphin Intertrade Corporation

Original FDA data

Every field from FDA enforcement report D-1250-2014, exactly as published.

Show all FDA fields

City: Miami
State: FL
Status: Terminated
Country: United States
Event ID: 65383
Address: 11314 Sw 135th Ct
Code information: All Lots
Postal code: 33186-4425
Report date: Apr 30, 2014
Product type: Drugs
Recall number: D-1250-2014
Classification: Class I
Recalling firm: Dolphin Intertrade Corporation
Product quantity: 8 bottles
Termination date: Jun 29, 2016
Reason for recall: Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Voluntary / mandated: Voluntary: Firm initiated
Product description: XIYOUJI QINGZHI CAPSULE, 300mg, 20 count box
Distribution pattern: Nationwide
Recall initiation date: May 20, 2013
Initial firm notification: E-Mail
Center classification date: Apr 18, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1250-2014, published Apr 30, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

Dolphin Intertrade Xiyouji Qingzhi Capsule Recall

Summary